Thatcher, Nick: search on Z-Library

Fundraising September 15, 2024 – October 1, 2024 About fundraising

The world's largest scientific articles store. 70,000,000+ articles for free.

Fundraising September 15, 2024 – October 1, 2024

Z-Library is one of the largest online libraries in the world that contains over 17,000,000 books and 84,837,000 articles. We aim to make literature accessible to everyone. Today (September 15, 2024) we've started additional fundraising to project maintenance and development.

Also UNLIMITED downloads (for 31 days after the day of making donation) are available for ALL contributors who will donate during the fundraising period till October 1, 2024.

About fundraisingRead more

Make a donation

1

Computational parasites and hydropower: A political ecology of Bitcoin mining on the Columbia River

Lally, Nick, Kay, Kelly, Thatcher, Jim

Journal:

Environment and Planning E: Nature and Space

Year:

2019

Language:

english

File:

PDF, 609 KB

english, 2019

2

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

Nick Thatcher, Alex Chang, Purvish Parikh, José Rodrigues Pereira, Tudor Ciuleanu, Joachim von Pawel, Sumitra Thongprasert, Eng Huat Tan, Kristine Pemberton, Venice Archer, Kevin Carroll

Journal:

Year:

2005

Language:

english

File:

PDF, 158 KB

english, 2005

3

The impact on the multidisciplinary team of molecular profiling for personalized therapy in non-small cell lung cancer

Blackhall, Fiona, Thatcher, Nick, Booton, Richard, Kerr, Keith

Journal:

Year:

2013

Language:

english

File:

PDF, 136 KB

english, 2013

4

Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study

Chang, Alex, Parikh, Purvish, Thongprasert, Sumitra, Tan, Eng Huat, Perng, Reury-Perng, Ganzon, Domingo, Yang, Chih-Hsin, Tsao, Chao-Jung, Watkins, Claire, Botwood, Nick, Thatcher, Nick

Journal:

Journal of Thoracic Oncology

Year:

2006

Language:

english

File:

PDF, 233 KB

english, 2006

5

Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non–Small Cell Lung Cancer

Gridelli, Cesare, de Castro Carpeno, Javier, Dingemans, Anne-Marie C., Griesinger, Frank, Grossi, Francesco, Langer, Corey, Ohe, Yuichiro, Syrigos, Konstantinos, Thatcher, Nick, Das-Gupta, Ashis, Trum

Journal:

Year:

2018

Language:

english

File:

PDF, 273 KB

english, 2018

6

Totality of evidence in the development of ABP 215, an approved bevacizumab biosimilar

Thomas, Michael, Thatcher, Nick, Goldschmidt, Jerome, Ohe, Yuichiro, McBride, Helen J, Hanes, Vladimir

Journal:

Year:

2019

Language:

english

File:

PDF, 2.13 MB

english, 2019

7

G1 control gene status is frequently altered in resectable non-small cell lung cancer

Daniel C. Betticher, Gavin R.M. White, Silvia Vonlanthen, Xuan Liu, Andreas Kappeler, Hans J. Altermatt, Nick Thatcher, Jim Heighway

Journal:

International Journal of Cancer

Year:

1997

Language:

english

File:

PDF, 591 KB

english, 1997

8

Advanced recurrent squamous cell carcinoma of the head and neck. Results of a chemotherapeutic regimen with adriamycin, bleomycin, 5-fluorouracil, methotrexate, and vitamin A

Nick Thatcher, George Blackledge, Derek Crowther

Journal:

Year:

1980

Language:

english

File:

PDF, 431 KB

english, 1980

9

Anti-T antibody in malignant melanoma patients. Influence of response and survival following chemotherapy—changes in serum levels following C parvum, BCG immunization

Dr. Nick Thatcher, Khalid Hashmi, James Chang, Ric Swindell, Derek Crowther

Journal:

Year:

1980

Language:

english

File:

PDF, 401 KB

english, 1980

10

Effects of Corynebacterium parvum on cellular immunity of cancer patients, assayed sequentially over 63 days

Nick Thatcher, Bill Lamb, Rick Swindell, Derek Crowther

Journal:

Year:

1981

Language:

english

File:

PDF, 419 KB

english, 1981

11

The “Hot spleen” phenomenon in metastatic malignant melanoma. Its incidence and relationship with the immune system

John Wagstaff, Kiran Phadke, Neville Adam, Nick Thatcher, Derek Crowther

Journal:

Year:

1982

Language:

english

File:

PDF, 501 KB

english, 1982

12

Three months' treatment with cyclophosphamide, VP-16-213 followed by methotrexate and thoracic radiotherapy for small cell lung cancer

Nick Thatcher, Roger D. James, Will P. Steward, Phil V. Barber, Dick Feinmann, Bob A. M. Lawson, Kevin B. Carroll

Journal:

Year:

1985

Language:

english

File:

PDF, 461 KB

english, 1985

13

Treatment of metastatic melanoma by 24-hour DTIC infusions and hemibody irradiation

Nick Thatcher, Heather Anderson, Roger James, Peter Davenport, Peter Craig

Journal:

Year:

1986

Language:

english

File:

PDF, 410 KB

english, 1986

14

Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer

Nick Thatcher, Tom Cerny, Ron Stout, Heather Anderson, Philip V. Barber, Roger J. Wolstenholme, Peter Barnes, Abdul Deiraniya

Journal:

Year:

1987

Language:

english

File:

PDF, 603 KB

english, 1987

15

Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour Group

Nick Thatcher, David B. Smith, Mike J. Lind, Heather Anderson, Joyce Barclay, Mahendra P. Chopra, Melville D. Fitzgerald

Journal:

Year:

1988

Language:

english

File:

PDF, 424 KB

english, 1988

16

High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma

Dr. Nick Thatcher, Mike Lind, Godfrey Morgenstern, Trevor Carr, Gill Chadwick, Robert Jones, Peter Craig

Journal:

Year:

1989

Language:

english

File:

PDF, 674 KB

english, 1989

17

Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma

Shane C. White, Paul Lorigan, Mark R. Middleton, Heather Anderson, Juan Valle, Yvonne Summers, Paul A. Burt, Ana Arance, Ron Stout, Nick Thatcher

Journal:

Year:

2001

Language:

english

File:

PDF, 124 KB

english, 2001

18

Epidermal growth factor receptor immunohistochemistry : Comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer

Fred R. Hirsch, Rafal Dziadziuszko, Nick Thatcher, Helen Mann, Claire Watkins, Dinah V. Parums, Georgina Speake, Brian Holloway, Paul A. Bunn Jr, Wilbur A. Franklin

Journal:

Year:

2008

Language:

english

File:

PDF, 151 KB

english, 2008

19

Lymphocyte function in the blood of patients with untreated non-hodgkin lymphoma: Influence of stage and pathology

Dr. Nick Thatcher, Nijole Gasiunas, Derek Crowther, Michael R. Potter

Journal:

Pediatric Blood & Cancer

Year:

1977

Language:

english

File:

PDF, 601 KB

english, 1977

20

A phase I study of rDNA alpha-2b interferon as a 6-week continuous intravenous infusion

David Smith, John Wagstaff, Nick Thatcher, Howard Scarffe

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1987

Language:

english

File:

PDF, 419 KB

english, 1987

21

In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue

Siow Ming Lee, Nick Thatcher, Derek Crowther, Geoffrey P Margison

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1992

Language:

english

File:

PDF, 817 KB

english, 1992

22

Role of colony stimulating factors (CSFs) in solid tumours: Results of an expert panel

Cesare Gridelli, Matti S. Aapro, Sandro Barni, Giordano Domenico Beretta, Giuseppe Colucci, Bruno Daniele, Lucia Del Mastro, Massimo Di Maio, Luigi De Petris, Francesco Perrone, Nick Thatcher, Filippo

Journal:

Critical Reviews in Oncology/Hematology

Year:

2007

Language:

english

File:

PDF, 187 KB

english, 2007

23

Expression of p16INK4a/p16α and p19ARF/p16β is frequently altered in non-small cell lung cancer and correlates with p53 overexpression

Vonlanthen, Silvia, Heighway, Jim, Tschan, Mario P, Borner, Markus M, Altermatt, Hans J, Kappeler, Andreas, Tobler, Andreas, Fey, Martin F, Thatcher, Nick, Yarbrough, Wendell G

Journal:

Year:

1998

Language:

english

File:

PDF, 470 KB

english, 1998

24

Randomized Phase IIIb Trial Evaluating the Continuation of Bevacizumab Beyond Disease Progression in Patients with Advanced Non-Squamous Non–Small-Cell Lung Cancer after First-Line Treatment with Bevacizumab Plus Platinum-Based Chemotherapy: Treatment Rationale and Protocol Dynamics of the AvaALL (MO22097) Trial

Cesare Gridelli, Jaafar Bennouna, Javier de Castro, Anne-Marie C. Dingemans, Frank Griesinger, Francesco Grossi, Antonio Rossi, Nick Thatcher, Elaine K. Wong, Corey Langer

Journal:

Clinical Lung Cancer

Year:

2011

Language:

english

File:

PDF, 268 KB

english, 2011

25

The value of anatomic staging and other prognostic factors in small cell lung cancer management: A view of European studies

Nick Thatcher, Heather Anderson, Paul Burt, Ron Stout

Journal:

Seminars in Radiation Oncology

Year:

1995

Language:

english

File:

PDF, 492 KB

english, 1995

26

ALK translocation and crizotinib in non-small cell lung cancer: An evolving paradigm in oncology drug development

Giorgio Scagliotti, Rolf A. Stahel, Rafael Rosell, Nick Thatcher, Jean-Charles Soria

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 892 KB

english, 2012

27

Lung cancer after treatment for Hodgkin's lymphoma: a systematic review

Paul Lorigan, John Radford, Anthony Howell, Nick Thatcher

Journal:

The Lancet Oncology

Year:

2005

Language:

english

File:

PDF, 300 KB

english, 2005

28

Where next for gefitinib in patients with lung cancer?

Fiona Blackhall, Malcolm Ranson, Nick Thatcher

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 127 KB

english, 2006

29

Lung cancer after treatment for breast cancer

Paul Lorigan, Raffaele Califano, Corinne Faivre-Finn, Anthony Howell, Nick Thatcher

Journal:

The Lancet Oncology

Year:

2010

Language:

english

File:

PDF, 102 KB

english, 2010

30

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study

Lucio Crinò, Eric Dansin, Pilar Garrido, Frank Griesinger, Janessa Laskin, Nick Pavlakis, Daniel Stroiakovski, Nick Thatcher, Chun-Ming Tsai, Yi-long Wu, Caicun Zhou

Journal:

The Lancet Oncology

Year:

2010

Language:

english

File:

PDF, 204 KB

english, 2010

31

The role of chemotherapy (CT) and supportive care (SC) in advanced non-small cell lung cancer (NSCLC)

Journal:

Year:

2002

Language:

english

File:

PDF, 79 KB

english, 2002

32

Targeted molecular mechanisms of epoetin alfa

Langer, Corey J., Hirsch, Fred R., Cortés-Funes, Hernan, Sawyer, Stephen T., Thatcher, Nick

Journal:

Year:

2003

Language:

english

File:

PDF, 342 KB

english, 2003

33

Options for first- and second-line therapy in small cell lung cancer — a workshop discussion

Thatcher, Nick, Eckardt, John, Green, Mark

Journal:

Year:

2003

Language:

english

File:

PDF, 635 KB

english, 2003

34

P-26 Phase II trial with RFS 2000 (9NC) in patients with advanced and/or metastatic non-small cell lung cancer (NSCLC)

Baka, Sofia, Lorigan, Paul, Danson, Sarah, White, Alison, Joyce, Patrick, Thatcher, Nick, Ranson, Malcolm

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

35

O-275 Ifosfamide, carboplatin and etoposide with mid-cycle vincristine (ICE-V) versus standard chemotherapy (C) in patients with small cell lung cancer (SCLC) and good performance status (PS): results of an MRC randomized trial (LU21)

Thatcher, Nick, Qian, Wendi, Girling, David J.

Journal:

Year:

2003

Language:

english

File:

PDF, 139 KB

english, 2003

36

Platinum-based chemotherapy with thoracic radiotherapy in stage III good performance status non-small cell lung cancer patients

Sofia Baka, Corinne Faivre-Finn, Pavlos Papakotoulas, Fiona Blackhall, Heather Anderson, Paul Lorigan, Nick Thatcher

Journal:

European Journal of Cancer Supplements

Year:

2005

Language:

english

File:

PDF, 878 KB

english, 2005

37

Small Cell Lung Cancer (SCLC); any progress?

Nick Thatcher, Corinne Faivre-Finn, Fiona Blackhall, Paul Taylor, Paul Lorigan

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 47 KB

english, 2007

38

The ISEL and BR21 trials – Outcomes similar or different?

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 111 KB

english, 2006

39

Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer

Eisen, Tim, Thatcher, Nick, Leyvraz, Serge, Miller, Wilson H., Couture, Felix, Lorigan, Paul, Lüthi, François, Small, David, Tanovic, Adnan, O’Brien, Mary

Journal:

Year:

2009

Language:

english

File:

PDF, 143 KB

english, 2009

40

Vaccines for the treatment of non-small cell lung cancer: Investigational approaches and clinical experience

Mellstedt, Håkan, Vansteenkiste, Johan, Thatcher, Nick

Journal:

Year:

2011

Language:

english

File:

PDF, 414 KB

english, 2011

41

Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group

Califano, Raffaele, Griffiths, Richard, Lorigan, Paul, Ashcroft, Linda, Taylor, Paul, Burt, Paul, Lee, Lip, Chittalia, Abbas, Harris, Margaret, Faivre-Finn, Corinne, Thatcher, Nick, Blackhall, Fiona

Journal:

Year:

2011

Language:

english

File:

PDF, 488 KB

english, 2011

42

Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin

Reck, Martin, Thatcher, Nick, Smit, Egbert F., Lorigan, Paul, Szutowicz-Zielinska, Ewa, Liepa, Astra M., Winfree, Katherine B., Peterson, Patrick, Guba, Susan C., Socinski, Mark A.

Journal:

Year:

2012

Language:

english

File:

PDF, 525 KB

english, 2012

43

Novel Therapies for the Treatment of Small-Cell Lung Cancer

Dr Ruth E. Board, Nick Thatcher, Paul Lorigan

Journal:

Year:

2006

Language:

english

File:

PDF, 136 KB

english, 2006

44

Modern Management of Small-Cell Lung Cancer

Roberta Ferraldeschi, Sofia Baka, Babita Jyoti, Corinne Faivre-Finn, Nick Thatcher, Dr Paul Lorigan

Journal:

Year:

2007

Language:

english

File:

PDF, 160 KB

english, 2007

45

Thoracic Radiation Therapy for Limited-Stage Small-Cell Lung Cancer: Unanswered Questions

Corinne Faivre-Finn, Paul Lorigan, Catharine West, Nick Thatcher

Journal:

Clinical Lung Cancer

Year:

2005

Language:

english

File:

PDF, 519 KB

english, 2005

46

Management of Unresectable Stage III Non–Small-Cell Lung Cancer with Combined-Modality Therapy: A Review of the Current Literature and Recommendations for Treatment

Neil A. Bayman, Fiona Blackhall, Pooja Jain, Lip Lee, Nick Thatcher, Corinne Faivre-Finn

Journal:

Clinical Lung Cancer

Year:

2008

Language:

english

File:

PDF, 140 KB

english, 2008

47

Chemotherapy and quality of life in advanced NSCLC – reply

Anderson, Heather, Carmichael, Jim, Nicolson, Marianne, Hopwood, Penny, Thatcher, Nick

Journal:

British Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 27 KB

english, 2001

48

Place de la gemcitabine dans les traitements combinationés de radiothérapie- chimiothérapie du cancer bronchique non a petites cellules de stade III

Journal:

American Journal of Cancer

Year:

2004

Language:

french

File:

PDF, 85 KB

french, 2004

49

The Value of Erythropoietin Therapy in Cancer Patients

Dr Richard Booton, Nick Thatcher

Journal:

American Journal of Cancer

Year:

2005

Language:

english

File:

PDF, 161 KB

english, 2005

50

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

Butts, Charles, Socinski, Mark A, Mitchell, Paul L, Thatcher, Nick, Havel, Libor, Krzakowski, Maciej, Nawrocki, Sergiusz, Ciuleanu, Tudor-Eliade, Bosquée, Lionel, Trigo, José Manuel, Spira, Alexander,

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 546 KB

english, 2014